LIVE CE Webinar! A Practical Guide to Peer Review for Clinicans (18 Nov 2026)

Wed, 18 Nov 2026 17:00:00 GMT

Wednesday, November 18, 2026

11:00 am - 12:00 pm CT/12:00 - 1:00 pm ET

Description:

Peer review is a core safeguard of scholarly publishing, yet few clinicians receive formal training in how to do it well. This interactive session will equip clinicians with a structured, practical framework for performing high-quality peer review, with an emphasis on real-world application and critical evaluation skills. Participants will review a sample peer review, work through an applied manuscript exercise, and see how pharmacists and physicians each bring a complementary perspective to evaluating a manuscript’s clinical and pharmacotherapeutic relevance.

Agenda:
Following introductions, speakers will review the purpose of peer review in scholarly publishing and present a structured framework for evaluating a manuscript. Attendees will then critique a sample peer review and complete an applied manuscript exercise using audience polling. The session will end with attendee Q&A.

Target Audience: An interprofessional audience, specifically pharmacists and physicians, practicing in infectious diseases and/or inpatient settings, including residents, fellows, and clinicians interested in scholarly activity.

Learning Objectives:

Describe the purpose of peer review in scholarly publishing
Apply a structured framework to evaluate a manuscript and distinguish major from minor issues
Distinguish characteristics of high-quality vs low-quality peer review comments
Identify the complementary roles pharmacists and physicians play in evaluating a manuscript’s clinical and pharmacotherapeutic relevance

Speakers:

Monica V. Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP, FMSHP
Clinical Pharmacy Specialist, Infectious Diseases
Outpatient ID/OPAT Clinics
Beth Israel Deaconess Medical Center

Alan E. Gross, PharmD, BCPS, BCIDP
Clinical Associate Professor, College of Pharmacy
University of Illinois Chicago

Accreditation:

Pharmacist

The Society of Infectious Diseases Pharmacists (SIDP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

UAN: 0672-0000-26-054-L01-P
CPE credit: 1.0 contact hour (0.1 CEU)
Type of activity: Application
Release date: November 18, 2026
ACPE Activity Fee: SIDP Member: Free / Non-Member: $10

To receive CE credit, participants must view the CE content, complete a post-test, and complete an evaluation. Proof of completion will be submitted to NABP CPE Monitor.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Participants are responsible for verifying credits were transferred successfully to your NABP eProfile account before the ACPE 60-day deadline. After the 60 day deadline, SIDP will no longer be able to report your credit(s) for this activity.

Funding: This activity is provided by SIDP. No external funding was received for this activity.

Disclosures: In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, SIDP asks all individuals involved in the development and presentation of CE activities to disclose all financial relationships with ineligible companies. All relevant financial relationships have been mitigated prior to the CE activity. The following financial relationships have been disclosed:

Dr. Monica Mahoney: Associate Editor of IDSA/OFID, Author/Consultand for UptoDate, Speaker for ASHP, Consultant/Advisor/Speaker for Seqirus.
Dr. Alan Gross: no relevant financial relationships with ineligible companies to disclose.
Program planners: Maureen Campion - Ad board for Shionogi, research funding from Paratek; Mark Biagi - Stock owner in Akero Therapeutics, Anixa Biosciences, BriaCell Therapeutics, Cabaletta Bio, CRISPR Therapeutics, ProQRTherapeutics, Recursion Pharmaceuticals, Summit Therapeutics, Syndax Pharmaceuticals, Vertex Pharmaceuticals, Viking Therapeutics
Presentation title and objectives were written by the planning committee and enhanced by AI. All enhancements were reviewed by a human.

Disclaimer: Faculty members are asked to disclose when any unlabeled/investigational use of pharmaceuticals and devices is being discussed. This activity is intended for educational purposes and should not be used as a substitute for care or advice from a professional. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of SIDP.

The planners and faculty of this continuing education activity have made all reasonable efforts to ensure the accuracy of the information presented in accordance with the latest available scientific knowledge at the time of publication. Healthcare professionals should verify all information and data with recommendations of other authorities before treating patients or employing any therapies described in this continuing education activity.

Australian Society for Antimicrobials 2027 Meeting (25 Feb 2027)

Thu, 25 Feb 2027 06:00:00 GMT

Australian Society for Antimicrobials 2027 Meeting

The 26th Annual Scientific Meeting of the Australian Society for Antimicrobials (ASA), Antimicrobials 2027, will take place 25–27 February 2027 at the Brisbane Convention & Exhibition Centre, Brisbane, Queensland. Access additional meeting information here.

Antimicrobials Conference 2027 (21 May 2027)

Sat, 22 May 2027 04:00:00 GMT

2027 Annual Meeting

Mark your calendars for

Antimicrobials Conference 2027

May 22-26 in Baltimore, MD

Baltimore Marriott Waterfront

with a pre-meeting PK/PD workshop May 22!

~Further details coming soon~

Antimicrobials Conference 2028 (03 May 2028)

Wed, 03 May 2028 05:00:00 GMT

2028 Annual Meeting

Mark your calendars for

Antimicrobials Conference 2028

May 3-6, 2028 in San Diego, California

Manchester Grand Hyatt San Diego